UCLA’s Roger Lo awarded $1 million to help prevent cancer relapse

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Roger Lo, a professor of medicine, dermatology and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, has received a $1 million “All-Star” grant from the V Foundation to develop strategies to prevent relapse in patients with advanced melanoma by targeting drug resistance before it takes root.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Cornell University has come to an agreement with the Trump administration that will unfreeze the university’s more than $250 million in interrupted federal research funding and “protect Cornell’s students from violations of federal civil rights laws, including from discrimination based on race, sex, or national origin, and promote America’s hardworking farming and rural communities” following accusations of antisemitism and discrimination in admissions.
With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login